StockData
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. (TRLV) stock

TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3032% below fair value
$8.68−0.67 (-7.17%)

Close on Nov 20, 2026Market cap $1.67BP/E –Yield –

Trulieve Cannabis free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Trulieve Cannabis's free cash flow for the twelve months ending Jun 30, 2026 was $202.56M, up 151.3% year over year. For fiscal 2025 it was $228.63M, up 53.6% from the year before. The highest annual figure on record is $228.63M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$228.63M+53.6%
FY2024Dec 31, 2024$148.88M-7.9%
FY2023Dec 31, 2023$161.60M–
FY2022Dec 31, 2022-$141.65M–
FY2021Dec 31, 2021-$263.00M–
FY2020Dec 31, 2020-$298.00K–
FY2019Dec 31, 2019-$52.76M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$32.13M-54.2%
Q1 FY2026Mar 31, 2026$42.22M+39.2%
Q4 FY2025Dec 31, 2025$55.81M–
Q3 FY2025Sep 30, 2025$72.41M–
Q2 FY2025Jun 30, 2025$70.08M+55.6%
Q1 FY2025Mar 31, 2025$30.33M-75.5%
Q4 FY2024Dec 31, 2024-$12.02M-109.8%
Q3 FY2024Sep 30, 2024-$7.78M-108.9%
Q2 FY2024Jun 30, 2024$45.03M–
Q1 FY2024Mar 31, 2024$123.66M–
Q4 FY2023Dec 31, 2023$122.23M+491.0%
Q3 FY2023Sep 30, 2023$87.16M–
Q2 FY2023Jun 30, 2023-$34.46M–
Q1 FY2023Mar 31, 2023-$13.32M–
Q4 FY2022Dec 31, 2022$20.68M–
Q3 FY2022Sep 30, 2022-$59.19M–
Q2 FY2022Jun 30, 2022-$100.18M–
Q1 FY2022Mar 31, 2022-$2.97M-126.5%
Q4 FY2021Dec 31, 2021-$147.18M–
Q3 FY2021Sep 30, 2021-$49.72M–
Q2 FY2021Jun 30, 2021-$77.31M-244.7%
Q1 FY2021Mar 31, 2021$11.20M–
Q4 FY2020Dec 31, 2020-$11.78M–
Q3 FY2020Sep 30, 2020-$38.27M–
Q2 FY2020Jun 30, 2020$53.43M–
Q1 FY2020Mar 31, 2020-$3.68M–

More Trulieve Cannabis figures

See a number that looks wrong?